The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response — Biological and Clinical Aspects

od Medová, Michaela, Aebersold, Daniel M., Zimmer, Yitzhak
Wydane 2013

A Comparative Analysis of Individual RAS Mutations in Cancer Biology

od Muñoz-Maldonado, Carmen, Zimmer, Yitzhak, Medová, Michaela
Wydane w Front Oncol (2019)

ProtRank: bypassing the imputation of missing values in differential expression analysis of proteomic data

od Medo, Matúš, Aebersold, Daniel M., Medová, Michaela
Wydane w BMC Bioinformatics (2019)

Editorial: Exploiting DNA Damage Response in the Era of Precision Oncology

od Zimmer, Yitzhak, Reinhardt, Hans Christian, Medová, Michaela
Wydane w Front Oncol (2020)

The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer

od Poliaková, Michaela, Aebersold, Daniel M., Zimmer, Yitzhak, Medová, Michaela
Wydane w Mol Cancer (2018)

MET Inhibition Results in DNA Breaks and Synergistically Sensitizes Tumor Cells to DNA-Damaging Agents Potentially by Breaching a Damage-Induced Checkpoint Arrest

od Medová, Michaela, Aebersold, Daniel Matthias, Blank-Liss, Wieslawa, Streit, Bruno, Medo, Matúš, Aebi, Stefan, Zimmer, Yitzhak
Wydane 2010

Profiling Invasiveness in Head and Neck Cancer: Recent Contributions of Genomic and Transcriptomic Approaches

od Nisa, Lluís, Aebersold, Daniel Matthias, Giger, Roland, Caversaccio, Marco Domenico, Borner, Urs, Medová, Michaela, Zimmer, Yitzhak
Wydane w Cancers (Basel) (2015)

Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer

od Piguet, Anne-Christine, Medová, Michaela, Keogh, Adrian, Glück, Astrid A., Aebersold, Daniel M., Dufour, Jean-François, Zimmer, Yitzhak
Wydane w Genes Cancer (2015)

KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET‐expressing tumor cells

od Leiser, Dominic, Medová, Michaela, Mikami, Kei, Nisa, Lluís, Stroka, Deborah, Blaukat, Andree, Bladt, Friedhelm, Aebersold, Daniel M., Zimmer, Yitzhak
Wydane w Mol Oncol (2015)

PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models

od Nisa, Lluís, Häfliger, Pascal, Poliaková, Michaela, Giger, Roland, Francica, Paola, Aebersold, Daniel Matthias, Charles, Roch-Philippe, Zimmer, Yitzhak, Medová, Michaela
Wydane w Mol Cancer (2017)

Hepatocyte growth factor secreted by bone marrow stem cell reduce ER stress and improves repair in alveolar epithelial II cells

od Nita, Izabela, Hostettler, Katrin, Tamo, Luca, Medová, Michaela, Bombaci, Giuseppe, Zhong, Jun, Allam, Ramanjaneyulu, Zimmer, Yitzhak, Roth, Michael, Geiser, Thomas, Gazdhar, Amiq
Wydane w Sci Rep (2017)

Enhancing CRISPR deletion via pharmacological delay of DNA-PKcs

od Bosch-Guiteras, Núria, Uroda, Tina, Guillen-Ramirez, Hugo A., Riedo, Rahel, Gazdhar, Amiq, Esposito, Roberta, Pulido-Quetglas, Carlos, Zimmer, Yitzhak, Medová, Michaela, Johnson, Rory
Wydane w Genome Res (2021)

Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury

od Melin, Nicolas, Sánchez-Taltavull, Daniel, Fahrner, René, Keogh, Adrian, Dosch, Michel, Büchi, Isabel, Zimmer, Yitzhak, Medová, Michaela, Beldi, Guido, Aebersold, Daniel M., Candinas, Daniel, Stroka, Deborah
Wydane w Cell Death Dis (2021)

Deciphering MET‐dependent modulation of global cellular responses to DNA damage by quantitative phosphoproteomics

od Bensimon, Ariel, Koch, Jonas P., Francica, Paola, Roth, Selina M., Riedo, Rahel, Glück, Astrid A., Orlando, Eleonora, Blaukat, Andree, Aebersold, Daniel M., Zimmer, Yitzhak, Aebersold, Ruedi, Medová, Michaela
Wydane w Mol Oncol (2020)

The LIM Protein Ajuba Augments Tumor Metastasis in Colon Cancer

od Dommann, Noëlle, Sánchez-Taltavull, Daniel, Eggs, Linda, Birrer, Fabienne, Brodie, Tess, Salm, Lilian, Baier, Felix Alexander, Medová, Michaela, Humbert, Magali, Tschan, Mario P., Beldi, Guido, Candinas, Daniel, Stroka, Deborah
Wydane w Cancers (Basel) (2020)

Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma

od Gavini, Jacopo, Dommann, Noëlle, Jakob, Manuel O., Keogh, Adrian, Bouchez, Laure C., Karkampouna, Sofia, Julio, Marianna Kruithof-de, Medova, Michaela, Zimmer, Yitzhak, Schläfli, Anna M., Tschan, Mario P., Candinas, Daniel, Stroka, Deborah, Banz, Vanessa
Wydane w Cell Death Dis (2019)

Exploiting DNA Damage Response in the Era of Precision Oncology

Wydane 2020